ILLUMINA, INC. cotiza a 264.57 USD y tiene una capitalización bursátil de $40.0B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; w…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $1.31 | $1.15 | $1.35 |
| Estimado | $1.36 | $1.23 | $1.06 | $1.23 |
| Sorpresa | — | +6.5% | +8.5% | +9.8% |
| Métrica | ILMN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 66.1% | 57.0% | +9.0% |
| Operating Margin | 18.6% | -38.6% | +57.2% |
| Net Margin | 19.6% | -33.6% | +53.1% |
| FCF Margin | 21.4% | -13.9% | +35.3% |
| ROE | 31.2% | -40.4% | +71.6% |
| ROA | 12.8% | -32.0% | +44.8% |
| Current Ratio | 2.08 | 2.84 | -0.76 |
| Debt / Equity | 0.55 | 0.28 | +0.27 |